Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Idarubicin
Trade Name
Zavedos Oral
Manufacturer
Pharmacia & Upjhon
Risk Category
D
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • antineoplastic, analogue of daunorubicin.
  • Fetal Risk
    Fetal Risk
  • embryotoxic and teratogenic in animals causing fetal loss, growth retardation, delayed ossification and skeletal defects.
  • No adequate human data but reported fetal death with its use during pregnancy without congenital malformations.
  • Occupational exposure of pregnant woman to antineoplastic drugs, carries risk to the fetus, including fetal loss and malformations.
  • Breast Feeding
    Breast Feeding
  • Contraindicated in breast feeding.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     6   +   1    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year